SCHEMBL176409

SCHEMBL176409

O=C(O)CCCCCCCCC(=O)OCCO

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 4/20 0.56
FFAR1 O14842 2/20 0.56
FFAR4 Q5NUL3 2/20 0.56
TSHR P16473 5/20 0.52
LMNA P02545 2/20 0.52
NFKB1 P19838 1/20 0.52
PMP22 Q01453 1/20 0.52
DGKA P23743 1/20 0.52
ALDH1A1 P00352 3/20 0.48
CAMK2A Q9UQM7 1/20 0.48
PAM P19021 2/20 0.47
MGLL Q99685 1/20 0.45
PPARG P37231 4/20 0.43
PPARD Q03181 4/20 0.43
PPARA Q07869 4/20 0.43
HDAC11 Q96DB2 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
TLR2 O60603 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28304556 1.00 GPR84 (0.56) GPR84FFAR1FFAR4TSHRLMNA
SCHEMBL729520 1.00 GPR84 (0.56) GPR84FFAR1FFAR4TSHRLMNA
SCHEMBL4159638 1.00 GPR84 (0.56) GPR84FFAR1FFAR4TSHRLMNA
SCHEMBL28287969 1.00 GPR84 (0.56) GPR84FFAR1FFAR4TSHRLMNA
Ammonia Solution, Strong SCHEMBL27527875 0.98 GPR84 (0.54) GPR84FFAR1FFAR4TSHRLMNA
Ammonia Solution, Strong SCHEMBL27470632 0.98 GPR84 (0.54) GPR84FFAR1FFAR4TSHRLMNA
Water SCHEMBL28518811 0.98 GPR84 (0.54) GPR84FFAR1FFAR4TSHRLMNA
Ammonia Solution, Strong SCHEMBL27593614 0.98 GPR84 (0.54) GPR84FFAR1FFAR4TSHRLMNA
SCHEMBL26442 0.98 GPR84 (0.52) GPR84FFAR1FFAR4TSHRLMNA
Ammonia Solution, Strong SCHEMBL7134656 0.96 GPR84 (0.50) GPR84FFAR1FFAR4TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 470 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117582513-A Drug delivery controllable release system based on shape memory degradable polyurethane and application thereof in treating bladder cancer 复旦大学附属中山医院 2024-02-23 CN claimed
CN-117567722-A Degradable polyurethane elastomer capable of recovering shape at body temperature and preparation method thereof 复旦大学附属中山医院 2024-02-20 CN claimed
CN-117547612-A Preparation method and application of bladder cancer drug release system based on fully degradable shape memory material 复旦大学附属中山医院 2024-02-13 CN claimed
US-20230165803-A1 BIOPOLYMER-ENCAPSULATED GLYCOSYLTRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS UNIV JOHNS HOPKINS (US) 2023-06-01 US claimed
CN-115716902-A Organic silicon modified wear-resistant TPU (thermoplastic polyurethane), and preparation method and application thereof 山东一诺威聚氨酯股份有限公司 2023-02-28 CN claimed
CN-113046018-B Hot melt adhesive, hot melt adhesive film, and preparation method and application thereof 常州市贝美家居科技有限公司 2022-11-01 CN claimed
CN-114736449-A Linear low-density stretch-proof winding film and preparation method thereof 太仓通盛包装材料有限公司 2022-07-12 CN claimed
US-20210386678-A1 BIOPOLYMER-ENCAPSULATED GLYCOSYL TRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS UNIV JOHNS HOPKINS (US) 2021-12-16 US claimed
CN-113046018-A Hot melt adhesive, hot melt adhesive film, and preparation method and application thereof 常州市贝美家居科技有限公司 2021-06-29 CN claimed
CN-107129856-B Freon-resistant lubricating grease composition and preparation method thereof 中国石油化工股份有限公司 2020-06-05 CN claimed
JP-2008533238-A 2008-08-21 JP claimed
US-20080139069-A1 SPUNBOND NON-WOVEN CONTAINING BAMBOO CHARCOAL AND METHOD FOR FABRICATING THE SAME TAIWAN TEXTILE RESEARCH INSTITUTE (TW) 2008-06-12 US claimed
EP-1856317-A4 POLYMERIC COMPOSITES HAVING ENHANCED REVERSIBLE THERMAL PROPERTIES AND METHODS OF FORMING THEREOF OUTLAST TECHNOLOGIES INC (US) 2008-04-02 EP claimed
EP-1856317-A2 POLYMERIC COMPOSITES HAVING ENHANCED REVERSIBLE THERMAL PROPERTIES AND METHODS OF FORMING THEREOF Outlast Technologies, Inc. (US) 2007-11-21 EP claimed
WO-2006098851-A2 POLYMERIC COMPOSITES HAVING ENHANCED REVERSIBLE THERMAL PROPERTIES AND METHODS OF FORMING THEREOF OUTLAST TECHNOLOGIES, INC. (US) 2006-09-21 WO claimed
US-20050208286-A1 Blending microcapsules containing phase change material with polyethylene; heat resistance OUTLAST TECHNOLOGIES LLC 2005-09-22 US claimed
US-6855422-B2 Multi-component fibers having enhanced reversible thermal properties and methods of manufacturing thereof OUTLAST TECHNOLOGIES GMBH (DE) 2005-02-15 US claimed
EP-0745647-B1 Blends of polyolefin graft copolymers and polycarbonates MONTELL NORTH AMERICA INC (US) 1999-08-18 EP claimed
US-5585434-A INCLUDES AT LEAST ONE ALIPHATIC POLYESTER MONTELL NORTH AMERICA INC. (US) 1996-12-17 US claimed
EP-0745647-A1 Blends of polyolefin graft copolymers and polycarbonates MONTELL NORTH AMERICA INC. (US) 1996-12-04 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210386678-A1 BIOPOLYMER-ENCAPSULATED GLYCOSYL TRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS PNLIP, TNNT2, UGGT1 GPR84 3977/4885FFAR1 3698/4885FFAR4 3368/4885
US-20230165803-A1 BIOPOLYMER-ENCAPSULATED GLYCOSYLTRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS PNLIP, TNNT2, UGGT1 GPR84 3812/4885FFAR1 3731/4885FFAR4 3354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.